Over- and under-treatment of lung cancer
- VernacularTitle:肺癌外科的过度治疗与治疗不足
- Author:
Junjie MA
1
;
Ting YE
2
;
Yang ZHANG
2
;
Haiquan CHEN
2
Author Information
1. Department of Thoracic Surgery, The Second People's Hospital of Liaocheng, The Second Hospital of Liaocheng Affiliated to Shandong First Medical University, Liaocheng, 252600, Shandong, P.R.China
2. Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Institute of Thoracic Cancer of Fudan University, Shanghai, 200032, P.R.China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
ground-glass nodule;
surgical treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(07):753-756
- CountryChina
- Language:Chinese
-
Abstract:
With the development and improved availability of low-dose computed tomography (LDCT), an increasing number of patients are clinically diagnosed with lung cancer manifesting as ground-glass nodules. Although radical surgery is currently the mainstay of treatment for patients with early-stage lung cancer, traditional anatomic lobectomy and mediastinal lymph node dissection (MLND) are not ideal for every patient. Clinically, it is critical to adopt an appropriate approach to pulmonary lobectomy, determine whether it is necessary to perform MLND, establish standard criteria to define the scope of lymph node dissection, and optimize the decision-making process. Thereby avoiding over- and under-treatment of lung cancer with surgical intervention and achieving optimal results from clinical diagnosis and treatment are important issues before us.
